Month: February 2019

High Tide Selected to Assist a Second Winner of the Ontario Cannabis Retail Lottery

CALGARY, Feb. 12, 2019 /CNW/ – High Tide Inc. (“High Tide” or the “Company”) (CSE:HITI) (Frankfurt:2LY) today announced that, subject to regulatory approval, the Company has been selected to assist with the establishment and operation of a retail cannabis store by a second winner of one of the 25 opportunities to apply for a licence to operate a cannabis retail store (the “Second Winner”) as a result of the Alcohol and Gaming Commission of Ontario’s (the “AGCO”) Expression of Interest Application Lottery conducted on January 11, 2019 (the “Lottery”). Subsequent to previously announcing that the Company had entered into a letter of intent with another beneficiary of the Lottery, the Second Winner and its representatives sought out High Tide’s support to help open

Continue Reading “High Tide Selected to Assist a Second Winner of the Ontario Cannabis Retail Lottery”

Canntab Enters into Supply Agreement with FSD Pharma and World Class Extractions on Organic Hemp Deal

TORONTO, Feb. 12, 2019 (GLOBE NEWSWIRE) — Canntab Therapeutics Limited (CSE: PILL, FSE: TBF1) (“Canntab”), a leader in the development of precision oral dose cannabis tablets and capsules, announced today that it has entered into a supply agreement (the “Agreement”) with FSD Pharma Inc. (“FSD Pharma”) and World Class Extractions Inc. (“World Class”) (the “Purchasers”) to purchase hemp flower from Thomas Elcome (the “Supplier”). Pursuant to the agreement, the Purchasers have agreed to buy approximately 1,000 kg of the Supplier’s 2018 hemp crop at a purchase price of $100.00 per kg per 1% of CBD extracted from the flower.

DC Acquisition Corp. Announces Proposed Qualifying Transaction with Mijem Inc.

VANCOUVER, BC / ACCESSWIRE / February 11, 2019 / DC Acquisition Corp. (TSXV: DCA.P) (the “Company”) is pleased to announce that it has entered into an arms-length non-binding letter of intent (the “LOI”) dated February 8, 2019 with Mijem Inc. (“Mijem”) to combine the businesses of the two companies. The LOI outlines the terms and conditions pursuant to which the Company and Mijem will complete a transaction that will result in a reverse take-over of the Company by Mijem (the “Proposed Transaction”). The Proposed Transaction will be an arm’s length transaction, and, if completed, will constitute the Company’s “Qualifying Transaction” (as such term is defined in Policy 2.4 of the TSX Venture Exchange (the “Exchange”)). Upon completion of the Proposed Transaction, the

Continue Reading “DC Acquisition Corp. Announces Proposed Qualifying Transaction with Mijem Inc.”

Cannara Biotech Shares to Begin Trading on the Frankfurt Exchange

MONTRÉAL, Feb. 11, 2019 /CNW/ – Cannara Biotech Inc. (“Cannara Biotech” or the “Company”) (CSE: LOVE) (FRA: 8CB), a vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced its common shares are listed for trading on the Frankfurt Stock Exchange under the trading symbol “8CB”. The Company’s common shares continue to be listed on the Canadian Securities Exchange under the trading symbol “LOVE”.  

Drone Delivery Canada to Unveil its 180kg (400lbs) Payload Cargo Delivery Drone ‘the Condor’ – February 19th at The Toronto Stock Exchange

TORONTO, Feb. 11, 2019 /PRNewswire/ – Drone Delivery Canada ‘DDC or the Company’ (TSX.V:FLT,OTC: TAKOF), is pleased to announce it will unveil DDC’s largest payload cargo delivery drone. With 180 kgs of capacity, ‘The Condor’ will be displayed at media, public and investor launch events at the TMX Broadcast Centre Gallery (located on the ground floor of 130 King St. West, Toronto, Ontario) on February 19, 2019.

FSD Pharma responds to and corrects misleading Auxly claims

TORONTO, Feb. 8, 2019 /CNW/ – FSD Pharma Inc.(CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9)  a licensed producer under the Cannabis Act, responded today to a press release by its former partner, Auxly Cannabis Group Inc. (“Auxly”) to correct misleading claims. 

Cannara Biotech Enters Cannabinoid-Infused Beverage Product Category

MONTRÉAL, Feb. 7, 2019 /CNW/ – Cannara Biotech Inc. (“Cannara Biotech” or the “Company”) (CSE: LOVE), a Montreal-based company that is building a vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced it has entered into a letter of intent with a leading Quebec microbrewery to develop cannabinoid-infused beverages. Following the regulations relating to edibles and beverages coming into effect next October, consumers will be able to purchase a variety of cannabinoid-infused beverages including non-alcoholic beer, kombucha and cider.

FSD Pharma Signs Collaboration and Profit-Sharing Agreement with Pharmastrip for Production and Delivery of Organic Medical Cannabis Infused in Oral Thin Film Strips

TORONTO, Feb. 7, 2019 /CNW/ – FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company), a licensed producer under the Cannabis Act, announced today that it has completed a strategic investment of $1.5 million in Pharmastrip Corp. and signed a definitive collaboration and profit sharing agreement with the company, effective January 23, 2019. Under the terms of the agreement, FSD will install Pharmastrip proprietary equipment at its facility in Cobourg, Ontario. FSD will use the equipment to manufacture organic medical cannabis infused in oral thin film strips. Pharmastrip will grant FSD an exclusive, perpetual license to manufacture and sell the oral thin film strips in Canada.

FSD Pharma Announces Strategic Business Developments

TORONTO, Feb. 6, 2019 /CNW/ – FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”), announced that its Board of Directors has concluded a strategic assessment of the Company and has implemented changes in leadership and business practices to optimize operations. Accordingly, the Company announced today that Dr. Raza Bokhari, Executive Co-Chairman, has been appointed interim Chief Executive Officer of FSD Pharma, effective immediately. Dr. Bokhari’s appointment follows the termination of Rupert Haynes.

Enthusiast Gaming Hires US Sales Team and Opens San Francisco Office

TORONTO, Feb. 06, 2019 (GLOBE NEWSWIRE) — Enthusiast Gaming Holdings Inc. (TSXV: EGLX) (OTCQB: EGHIF), (“Enthusiast” or the “Company”), a gaming company building the world’s largest community of authentic gamers, is pleased to announce that it has opened a US-based office and hired a sales team to drive advertising sales and increase annual revenue. The US-based sales team is based in San Francisco and will be responsible for leading North American sales. This expands the company’s current reach with a sales team in San Francisco, London, UK, and the corporate head office in Toronto. The company kicked off the opening of the sales office with a West Coast advertising roadshow, meeting with top gaming publishers, global brands, and media agencies.